Health
AstraZeneca COVID-19 shot candidate shows promise among elderly in trials – Reuters
A potential COVID-19 vaccine developed by AstraZeneca Plc and Oxford University produced a strong immune response in older adults, giving hope it may protect some…
LONDON, Nov 19 (Reuters) – A potential COVID-19 vaccine developed by AstraZeneca Plc and Oxford University produced a strong immune response in older adults, giving hope it may protect some of those most vulnerable to the disease, data from mid-stage trials showed.
The data, reported in part last month but published in full in The Lancet medical journal on Thursday, suggest that those aged over 70 – who are at higher risk of serious illness and death from COVID-19 – could build robust immunity to…
-
General12 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News13 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
Noosa News21 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General19 hours agoCrowe toasts talkback titan for platforming ‘voiceless’